Duration of intra-aortic balloon pump use and related complications

Acute Cardiac Care

Volumn 16, Issue 2, 2014, Pages 74-77

  Boudoulas, Konstantinos Dean ^a   Bowen, Theodore ^a   Pederzolli, Andrew ^a   Pfahl, Kyle ^a   Pompili, Vincent J ^a   Mazzaferri Jr , Ernest L ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Complication; Intra aortic balloon pump

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; GLYCOPROTEIN IIIA;

ADULT; ANTICOAGULATION; AORTA DISSECTION; ARTERIOVENOUS FISTULA; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; FALSE ANEURYSM; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART HEMODYNAMICS; HEMATOMA; HEMATURIA; HUMAN; INTRAAORTIC BALLOON PUMP; LEG ISCHEMIA; MALE; MESENTERIC ISCHEMIA; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROPERITONEAL HEMORRHAGE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VASCULAR DISEASE;

AGED; ELECTROCARDIOGRAPHY; FEMALE; HEMODYNAMICS; HEMORRHAGE; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 84899838417     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.3109/17482941.2014.889311     Document Type: Article

References (26)

1. Saia F , Grigioni F , Marzocchi A, Branzi 1. A. Management of acute left ventricular dysfunction aft er primary percutaneous coronary intervention for ST elevation acute myocardial infarction . Am Heart J. 2010 ; 160 : S16-S21
2. Bahekar A, Singh M, Singh S, Bhuriya R, Ahmad K, Khosla S, et al. Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: A meta-analysis . J Cardiovasc Pharmacol Th er. 2012 ; 17 : 44-56
3. Gu J, Hu W, Xiao H, Feng X, Chen Y, Zhang D. Intra-aortic balloon pump improves clinical prognosis and attenuates C-reactive protein level in acute STEMI complicated by cardiogenic shock. Cardiology 2010; 117: 75-80
4. Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK, et al. . Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: A report from the shock trial registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol. 2000; 36(Suppl. A): 1123-9
5. Brodie BR, Stuckey TD, Hansen C, Muncy D. Intraaortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction . Am J Cardiol. 1999 ; 84 : 18-23
6. Th iele H , S ick P , B oudriot E , D iederich K W, H ambrecht R , Niebauer J . Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005; 26: 1276-83
7. S eyfarth M , S ibbing D , B auer I , F rö h lich G , B ott-Flü g el L , Byrne R , et al. . A randomized clinical trial to evaluate the safety and effi cacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction . J Am Coll Cardiol. 2008 ; 52: 1584-8
8. C heng J M, d en Uil C A, v an Der Ent M , J ewbali L S, van Domburg RT , et al. . Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: A Ameta-analysis of controlled trials. Eur Heart J. 2009 ; 30 : 2102-8
9. Perera D, Stables R, Th omas M, Booth J, Pitt M, Blackman D, et al.; BCIS-1 Investigators. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention a randomized controlled trial . JAMA. 2010 ; 304 : 867-74
10. Th iele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J , et al. . Intraaortic balloon support for myocardial infarction with cardiogenic shock . N Engl J Med. 2012 ; 367 : 1287-96
11. Boudoulas KD, Pederzolli A, Saini U, Gumina RJ, Mazzaferri EL Jr , Davis M , et al. . Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous coronary intervention: Vascular complications and incidence of bleeding . Acute Card Care. 2012 ; 14 : 120-4
12. P arissis H , S oo A , A l-Alao B . I ntraaortic balloon pump: Literature review of risk factors related to complications of the intraaortic balloon pump . J Cardiothorac Surg. 2011 ; 6 : 147
13. V alente S , L azzeri C , C rudeli E , C hiostri M , G iglioli C , Bernardo P , et al. . Intraaortic balloon pump: Incidence and predictors of complications in the Florence registry . Clin Cardiol. 2012 ; 35 : 200-4
14. Sjauw KD, Engstr ö m AE, Vis MM, van Der Schaaf RJ, Baan J Jr, Koch KT , et al. . A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: Should we change the guidelines? E ur Heart J. 2 009; 3 0: 4 59- 6 8
15. Mahmoudi M, Hauville C, Gaglia MA Jr, Sardi G, Torguson R, Xue Z , et al. . The impact of intra-aortic balloon counter-pulsation on in-hospital mortality in patients presenting with anterior ST-elevation myocardial infarction without cardiogenic shock. Cardiovasc Revasc Med. 2012; 13: 328-30
16. Ohman EM, George BS, White CJ, Kern MJ, Gurbel PA, Freedman RJ , et al. . Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The randomized IABP study group. Circulation 1994 ; 90 : 792-9
17. Stone GW, Marsalese D, Brodie BR, Griffi n J J, D onohue B , Costantini C , et al. . A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second primary angioplasty in myocardial infarction (PAMI-II) trial investigators. J Am Coll Cardiol. 1997; 29: 1459-67
18. van? t Hof AW, Liem AL, de Boer MJ, Hoorntje JC, Suryapranata H, Zijlstra F . A randomized comparison of intraaortic balloon pumping aft er primary coronary angioplasty in high risk patients with acute myocardial infarction . Eur Heart J. 1999 ; 20 : 659-65
19. M ejia V M, N aidu S S, H ermann H . S upport devices for high-risk percutaneous coronary interventions . In: Topol EJ , editor . Textbook of interventional cardiology 5th edition. Philadelphia, PA: Saunders Elsevier ; 2008 . pp. 643 - 4
20. T rost J C, H illis L D. I ntra-aortic balloon counterpulsation. A m J Cardiol. 2006; 97: 1391-8
21. Williams DO, Korr KS, Gewirtz H, Most AS. The effect of intraaortic balloon counterpulsation on regional myocardial blood fl ow and oxygen consumption in the presence of coronary artery stenosis in patients with unstable angina. Circulation 1982; 66: 593-7
22. Kern MJ, Aguirre F, Bach R, Donohue T, Siegel R, Segal J. Augmentation of coronary blood fl ow by intraaortic balloon pumping in patients aft er coronary angioplasty . Circulation 1993 ; 87 : 500-11
23. Prondzinsky R, Unverzagt S, Russ M, Lemm H, Swyter M, Wegener N , et al. . Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: The prospective, randomized IABP shock trial. Shock 2012; 37: 378-84
24. Cook DJ, Reeve BK, Guyatt GH, Heyland DK, Griffi th L E, Buckingham L , et al. . Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA. 1996; 275: 308-14
25. Cook DJ, Witt LG, Cook RJ, Guyatt GH. Stress ulcer prophylaxis in the critically ill: A meta-analysis . Am J Med. 1991 ; 91 : 519-27
26. A lhazzani W , A lenezi F , J aeschke R Z, M oayyedi P , C ook D J. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: A systematic review and meta-analysis . Crit Care Med. 2013 ; 41 : 693-705